Difference between revisions of "Committees"
Jump to navigation
Jump to search
m |
m |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | '''[https://tinyurl.com/QIBA-Org-2020-05-28 QIBA Committee Organization Chart ( | + | '''[https://tinyurl.com/QIBA-Org-2020-05-28 QIBA Committee Organization Chart (March 2021)]''' |
[[Committee Organization]] | [[Committee Organization]] | ||
| Line 9: | Line 9: | ||
:* '''[[CT Coordinating Committee]]''' | :* '''[[CT Coordinating Committee]]''' | ||
::* [[CT Volumetry Biomarker Ctte|CT Volumetry Biomarker Committee]] | ::* [[CT Volumetry Biomarker Ctte|CT Volumetry Biomarker Committee]] | ||
| − | |||
::* [[CT Small Lung Nodule Biomarker Ctte|CT Small Lung Nodule Biomarker Committee]] | ::* [[CT Small Lung Nodule Biomarker Ctte|CT Small Lung Nodule Biomarker Committee]] | ||
| − | |||
::* [[Lung Density Biomarker Ctte|Lung Density Biomarker Committee]] | ::* [[Lung Density Biomarker Ctte|Lung Density Biomarker Committee]] | ||
:::* Airway Measurement TF | :::* Airway Measurement TF | ||
| − | |||
::* [[CT Angiography Biomarker Ctte|CT Angiography Biomarker Committee]] | ::* [[CT Angiography Biomarker Ctte|CT Angiography Biomarker Committee]] | ||
| Line 35: | Line 32: | ||
:::* Profile Compliance TF | :::* Profile Compliance TF | ||
:::* FDG-PET UPICT TF | :::* FDG-PET UPICT TF | ||
| − | ::* [[Myocardial Blood Flow Biomarker Committee|Myocardial Blood Flow Biomarker Committee]] | + | ::* [[PET Myocardial Blood Flow Biomarker Committee|PET Myocardial Blood Flow Biomarker Committee]] |
::* [[PET_Amyloid_Biomarker_Ctte|PET-Amyloid Biomarker Committee]] | ::* [[PET_Amyloid_Biomarker_Ctte|PET-Amyloid Biomarker Committee]] | ||
::* [[SPECT Biomarker Ctte|SPECT Biomarker Committee]] | ::* [[SPECT Biomarker Ctte|SPECT Biomarker Committee]] | ||
| Line 51: | Line 48: | ||
:::* Clinical Applications TF | :::* Clinical Applications TF | ||
| + | :* '''[[QIBA Sustainability Implementation Committee (QSIC)]]''' | ||
:* '''[[Process Coordinating Committee]]''' | :* '''[[Process Coordinating Committee]]''' | ||
:* '''[[Metrology Committee]]''' | :* '''[[Metrology Committee]]''' | ||
| + | :* '''[[Communications Committee]]''' | ||
Revision as of 21:37, 18 March 2021
QIBA Committee Organization Chart (March 2021)
-
- fMRI Biomarker Committee
- MR Elastography Biomarker Committee
- PDFF (Proton Density Fat Fraction) Biomarker Committee
- MSK (Musculoskeletal) Biomarker Committee
- Diffusion Weighted Imaging (DWI) MR Biomarker Committee
- Dynamic Contrast Enhanced (DCE) MRI Biomarker Committee
- Dynamic Susceptibility Contrast (DSC) MRI Biomarker Committee
- Diffusion Tensor Imaging (DTI) MRI Biomarker Committee
- Arterial Spin Labeling (ASL) Biomarker Committee
- (Dissolved) PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee
-
- AIUM/QIBA Pulse-Echo Quantitative Ultrasound Biomarker Committee
- AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Committee
- System Dependencies/Phantom Testing/Clinical Validation
- System Dependencies/Phantom Testing TF
- Clinical Applications TF
- (Dissolved) QIBA/RIC ctte and QIDW Oversight Committee
- (Dissolved) Committee on Open Image Archives
See Also
- qiba@rsna.org - Any information and coordination requests
- Committee Template - Template for new Committee Wiki Pages
- Committee Organization - Committee Membership and Responsibilities
- HIT Standards Community Calendar for potential conflicts. Note: it contains multi-day events, not individual tcons etc.